EMBCEmbecta Corp.
$3.35-66% 1Y
$3.35
$2.8952 weeks$14.20
The financials
Embecta Corp. by the numbers
Embecta Corp. (EMBC) reported revenue of $272M in Q3 2026 (quarter ended Jun 30, 2026), down 8.1% from the same quarter a year earlier. That came with a gross margin of 56% and net income of $21M (7.8% of revenue). For the full year FY2025, revenue was $1.08B (−3.8% year on year) and net income $95M. The next results filing is expected around Nov 24, 2026, the same week as a year ago.
| Income statement | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $272M | $296M | −8.1% |
| Gross profit | $153M | $197M | −22% |
| Operating income | $49M | $94M | −48% |
| Net income | $21M | $46M | −54% |
| Diluted EPS | $0.36 | $0.78 | −54% |
Medical Instruments & Supplies
Ranks #3 of 21 by RyuScore